![Michael Berry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Berry
Technik-/Wissenschafts-/F&E-Leiter bei
EVEREST MEDICINES LIMITED
Profil
Michael Berry is currently the Chief Technology Officer at Everest Medicines Ltd. He previously worked as the Senior Director of Bioprocess Development at Portola Pharmaceuticals, Director at ARCA biopharma, Director of Manufacturing Sciences & Technology at Novartis Vaccines & Diagnostics SL, and Vice President at Dynavax Technologies Corp.
He is also the Chief Technical Operations Officer at Clover Biopharmaceuticals Ltd. Berry received his undergraduate degree from De Montfort University, his graduate degree from The University of Manchester, and his doctorate from the University of Manitoba.
Aktive Positionen von Michael Berry
| Unternehmen | Position | Beginn |
|---|---|---|
| EVEREST MEDICINES LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 15.06.2023 |
Ehemalige bekannte Positionen von Michael Berry
| Unternehmen | Position | Ende |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01.08.2017 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.02.2015 |
Novartis Vaccines & Diagnostics SL | Corporate Officer/Principal | 01.09.2013 |
| ARCA BIOPHARMA | Direktor/Vorstandsmitglied | 01.05.2009 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Michael Berry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
72
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
De Montfort University
 De Montfort University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARCA biopharma, Inc.
 ARCA biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops genetic therapies for heart failure and cardiovascular diseases | Health Technology |
Novartis Vaccines & Diagnostics SL | |
Everest Medicines Ltd.
 Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
Clover Biopharmaceuticals Ltd.
 Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
